The 1st Regional Dengue Symposium will be held from 3-4 November, 2015 in Rio de Janeiro, Brazil.

The main objective of the meeting is to provide a common ground for discussion and exchange of ideas to help overcome the obstacles in reducing the rate of dengue morbidity and mortality in the region.

Given the complicated nature of dengue fever, the interactions between its four serotypes and the range of vaccine types under development, monitoring the long term effectiveness of these vaccines is crucial and necessary.

  • Review the currently available knowledge and experience for surveillance, detection, diagnosis, management and treatment of dengue.
  • Learn from the experiences of countries in the Americas who have been focusing on their social and economic context in order to generate more information.
  • Review important topics of high scientific complexity (vaccines, new technologies, available tools for prevention and control of dengue, economic burden of dengue)
  • Provide a forum for the discussion of topics surrounding vaccine introduction with particular focus on vaccine implementation and roll out including: financial issues, operative factors, regulatory issues, SAGE process for global recommendation, vaccine schedules,target groups (age), co-administration, safety studies, alternative dengue diagnostics and strategic advocacy and communications.


all logos




Program Committee

Annelies Wilder-Smith, Dengue Vaccine Initiative
Giovanini Coelho, Ministry of Health, Brazil
In-Kyu Yoon, International Vaccine Institute
Jon Kim Andrus, Sabin Vaccine Institute
José Luis San Martin, Pan American Health Organization
Luis Geraldo Castellanos, Pan American Health Organization